Trust Company of Vermont’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$7.96K Sell
1,110
-1,250
-53% -$9.88K ﹤0.01% 881
2025
Q3
$25.2K Buy
2,360
+30
+1% +$294 ﹤0.01% 694
2025
Q2
$22.6K Sell
2,330
-838
-26% -$8.64K ﹤0.01% 695
2025
Q1
$47.2K Buy
3,168
+406
+15% +$6.24K ﹤0.01% 525
2024
Q4
$41.2K Buy
2,762
+136
+5% +$2.22K ﹤0.01% 556
2024
Q3
$50.2K Buy
2,626
+1,372
+109% +$28.4K ﹤0.01% 517
2024
Q2
$26K Sell
1,254
-44
-3% -$874 ﹤0.01% 568
2024
Q1
$24.4K Buy
+1,298
New +$22.3K ﹤0.01% 585

Other funds holding OGN

Trust Company of Vermont's OGN Position: Q4 2025 in Review

Trust Company of Vermont reduced its Organon & Co (OGN) stake by 53% in Q4 2025, selling an estimated $9.88K and leaving 1,110 shares worth $7.96K. The position accounts for ﹤0.01% of the portfolio, ranked #881.

Trust Company of Vermont first reported a position in OGN in Q1 2024 and has held it in 8 quarters since. The position peaked at $50.2K in Q3 2024. 632 funds tracked by Wall St. Rank hold OGN as of Q4 2025.

  • Trust Company of Vermont held 1,110 shares of Organon & Co worth $7.96K as of Q4 2025.
  • Trust Company of Vermont sold 1,250 Organon & Co shares in Q4 2025, an estimated $9.88K.
  • Organon & Co made up ﹤0.01% of Trust Company of Vermont's portfolio in Q4 2025, its #881 holding.
  • Trust Company of Vermont first reported a position in Organon & Co in Q1 2024 and has held it in 8 quarters since.
  • Trust Company of Vermont's Organon & Co position peaked at $50.2K in Q3 2024.
  • 632 funds tracked by Wall St. Rank held Organon & Co as of Q4 2025.

Based on Trust Company of Vermont's 13F filing for Q4 2025, filed 16 Jan 2026.